Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 92 pseudogene 3 (ENSG00000269421) is classified as a pseudogene related to Zinc finger protein 92. Pseudogenes are genomic DNA sequences similar to functional genes but generally do not encode functional proteins. The canonical gene, ZNF92, is a C2H2-type zinc finger transcription factor predicted to bind DNA and regulate gene expression. Pseudogenes like this are typically not considered therapeutic targets, have no established biological function or disease association, and do not interact with drugs. They may represent remnants of evolutionary gene duplication or loss of function. This entry is not a legitimate target molecule or receptor for drug development or disease application. The canonical version, ZNF92, has an Ensembl ID of ENSG00000146757—not ENSG00000269421.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 92 pseudogene 3 (ZNF92-ps3).